SCAI and CAIC Announce the Formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI) – Cath Lab Digest

April 3, 2020 The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of Interventional Cardiology (CAIC) have announced the formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI).

The study will be chaired by Tim Henry, MD (SCAI) and Payam Dehghani, MD (CAIC). Any COVID-19 positive patients or persons under investigation (PUI) with ST-Segment Elevation or new-onset left bundle branch block with a clinical correlate of myocardial ischemia (chest pain, dyspnea, cardiac arrest, hemodynamic instability) will be in enrolled. The data will be compared to an age and gender-matched control population from the existing Midwest STEMI Consortium, which is a large (>15,000), prospective multi-center registry of consecutive STEMI patients. The NACMI registry has pending central IRB approval and will have an EKG and angiographic core lab.

Interested sites can designate a local principal investigator and contact either SCAI PI Tim Henry (Tim.Henry@thechristhospital.com), CAIC PI Payam Dehghani (pdehghani@me.com) or the data coordinating center (santiago.garcia@allina.com or ross.garberich@allina.com) to obtain participating site information.

We believe that this registry has the potential to provide critically important time-sensitive data to inform the management and treatment guidelines applicable to COVID-19 patients.

Source: SCAI COVID-19 Resources

Originally posted here:
SCAI and CAIC Announce the Formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI) - Cath Lab Digest